A combined human in silico and CRISPR/Cas9-mediated in vivo zebrafish based approach for supporting gene target validation in early drug discovery (2021)
Attributed to:
External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter
(EXCITEME)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.09.14.460241
Publication URI: http://dx.doi.org/10.1101/2021.09.14.460241
Type: Preprint